| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M001202200 |
| P698 | PubMed publication ID | 10751398 |
| P2093 | author name string | Lee TH | |
| Yoon WH | |||
| Park JH | |||
| Ahn JH | |||
| Hong SY | |||
| Kang SG | |||
| P2860 | cites work | Involvement of 5'-flanking kB-like sites within bcl-x gene in silica-induced bcl-x expression | Q23912832 |
| Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 | ||
| IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival | Q24323200 | ||
| The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex | Q24323338 | ||
| The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases | Q24532851 | ||
| IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases | Q24533214 | ||
| Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors | Q24600405 | ||
| NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes | Q24685661 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
| Death receptors: signaling and modulation | Q28280897 | ||
| Genomic organization and physical map of the human inhibitors of apoptosis: HIAP1 and HIAP2 | Q28294295 | ||
| IAP family proteins--suppressors of apoptosis | Q28297514 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40 | Q28610812 | ||
| An essential role for NF-kappaB in preventing TNF-alpha-induced cell death | Q29614707 | ||
| NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
| Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation | Q36575274 | ||
| Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control | Q36580820 | ||
| Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. | Q36851742 | ||
| Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells | Q38326377 | ||
| Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons | Q38326966 | ||
| Characterization of the mouse epidermal growth factor promoter and 5'-flanking region. Role for an atypical TATA sequence | Q38351260 | ||
| Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene | Q40647678 | ||
| Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis | Q41343773 | ||
| Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death | Q41678654 | ||
| A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. | Q42165830 | ||
| Self-association of the Death Domains of the p55 Tumor Necrosis Factor (TNF) Receptor and Fas/APO1 Prompts Signaling for TNF and Fas/APO1 Effects | Q59707705 | ||
| Epstein-Barr virus and Hodgkin's disease | Q72966219 | ||
| The inhibitors of apoptosis (IAPs) and their emerging role in cancer | Q77900361 | ||
| The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase | Q77927046 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| NF-κB | Q411114 | ||
| membrane protein | Q423042 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 18022-18028 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene | |
| P478 | volume | 275 |
| Q34767059 | A decision between life and death during TNF-alpha-induced signaling |
| Q24295232 | A splice variant of stress response gene ATF3 counteracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator |
| Q40799292 | Activation of noncanonical NF-kappaB signaling by the oncoprotein Tio. |
| Q34336439 | African swine fever virus IAP-like protein induces the activation of nuclear factor kappa B |
| Q40654479 | Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies |
| Q35743146 | Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks |
| Q24304385 | Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis |
| Q34029386 | CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter |
| Q38663042 | Cell cycle-dependent expression of cIAP2 at G2/M phase contributes to survival during mitotic cell cycle arrest |
| Q42867603 | Cellular inhibitor of apoptosis-2 is a critical regulator of apoptosis in airway epithelial cells treated with asthma-related inflammatory cytokines |
| Q35531894 | Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer. |
| Q40161639 | Cyclosporin A and FK506 inhibit IL-12p40 production through the calmodulin/calmodulin-dependent protein kinase-activated phosphoinositide 3-kinase in lipopolysaccharide-stimulated human monocytic cells |
| Q33183756 | Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-kappaB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis |
| Q38355344 | Cytokine-mediated induction of anti-apoptotic genes that are linked to nuclear factor kappa-B (NF-kappaB) signalling in human islets and in a mouse beta cell line |
| Q34653221 | DBC1 is a suppressor of B cell activation by negatively regulating alternative NF-κB transcriptional activity. |
| Q33549652 | Dexamethasone inhibits TRAIL- and anti-cancer drugs-induced cell death in A549 cells through inducing NF-kappaB-independent cIAP2 expression |
| Q34359416 | Differential regulation of the inhibitor of apoptosis ch-IAP1 by v-rel and the proto-oncogene c-rel. |
| Q40375014 | Distinct role of calmodulin and calmodulin-dependent protein kinase-II in lipopolysaccharide and tumor necrosis factor-alpha-mediated suppression of apoptosis and antiapoptotic c-IAP2 gene expression in human monocytic cells |
| Q35114550 | Effect of age on molecular signaling of TNF-α-induced apoptosis in human lymphocytes |
| Q57369846 | Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells |
| Q39604074 | Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. |
| Q92477714 | Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia |
| Q24299181 | Fas-associated Factor-1 Inhibits Nuclear Factor-κB (NF-κB) Activity by Interfering with Nuclear Translocation of the RelA (p65) Subunit of NF-κB |
| Q40628592 | Functional Effects of TNF-α on a Human Follicular Dendritic Cell Line: Persistent NF-κB Activation and Sensitization for Fas-Mediated Apoptosis |
| Q40746598 | Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis |
| Q90480702 | Hepatitis B virus upregulates cellular inhibitor of apoptosis protein 2 expression via the PI3K/AKT/NF-κB signaling pathway in liver cancer |
| Q40430288 | Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis |
| Q37302745 | IAP-targeted therapies for cancer |
| Q46853665 | Immunomodulatory effects of erythromycin and its derivatives on human T-lymphocyte in vitro |
| Q38349616 | Induction of cIAP-2 in Human Colon Cancer Cells through PKCδ/NF-κB |
| Q47811742 | JunD mediates survival signaling by the JNK signal transduction pathway |
| Q24293656 | Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase |
| Q35143975 | Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 |
| Q38391583 | Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. |
| Q41173599 | Molecular mechanisms of signaling via the docosanoid neuroprotectin D1 for cellular homeostasis and neuroprotection |
| Q29619302 | NF-kappaB at the crossroads of life and death |
| Q37274168 | NOR-1/NR4A3 regulates the cellular inhibitor of apoptosis 2 (cIAP2) in vascular cells: role in the survival response to hypoxic stress |
| Q35829878 | NPD1-mediated stereoselective regulation of BIRC3 expression through cREL is decisive for neural cell survival |
| Q36104043 | New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies |
| Q24650793 | Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor |
| Q92384079 | Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer |
| Q36961875 | Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. |
| Q33316851 | Phosphatidylinositol 3-kinase signaling in proliferating cells maintains an anti-apoptotic transcriptional program mediated by inhibition of FOXO and non-canonical activation of NFkappaB transcription factors |
| Q36175739 | Physical and functional interaction between the ID1 and p65 for activation of NF-κB |
| Q33615280 | Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells |
| Q40555067 | Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c-IAP1 and c-IAP2) in vitro |
| Q36944175 | Recurrent overexpression of c-IAP2 in EBV-associated nasopharyngeal carcinomas: critical role in resistance to Toll-like receptor 3-mediated apoptosis |
| Q39160772 | Regulated expression of inhibitor of apoptosis protein 3 in the rat corpus luteum. |
| Q45390987 | Regulation of IAPs gene family by interleukin-1 alpha and Epstein-Barr virus in nasopharyngeal carcinoma |
| Q33672257 | Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms |
| Q27011510 | Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications |
| Q35049033 | SUMOylation is required for optimal TRAF3 signaling capacity |
| Q33707613 | Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions |
| Q24670288 | Soluble receptor (DcR3) and cellular inhibitor of apoptosis-2 (cIAP-2) protect human cytotrophoblast cells against LIGHT-mediated apoptosis |
| Q36081375 | TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients |
| Q35782897 | Targeting endogenous inhibitors of apoptosis for treatment of cancer, stroke and multiple sclerosis. |
| Q21133696 | The RNA degradation pathway regulates the function of GAS5 a non-coding RNA in mammalian cells |
| Q26998401 | The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease |
| Q42288562 | The opposing roles of cellular inhibitor of apoptosis proteins in cancer |
| Q33269185 | Transcriptional profiling of the LPS induced NF-kappaB response in macrophages |
| Q33308790 | Transient and sustained oxidative stress differentially activate the JNK1/2 pathway and apoptotic phenotype in H9c2 cells |
| Q74411614 | Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury |
| Q45875183 | c-IAP2 is induced by ionizing radiation through NF-kappaB binding sites |
| Q50849341 | cIAP-2 protects cardiac fibroblasts from oxidative damage: an obligate regulatory role for ERK1/2 MAPK and NF-κB. |
| Q43777713 | cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18–Infected Lung Cancer |
Search more.